A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Gardiner, Robert A., Levin, Gregory, Wall, Bradley, Joseph, David, Chambers, Suzanne K. and Galvao, Daniel A. (2009) A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer, 9 210: xx-xx.


Author Newton, Robert U.
Taaffe, Dennis R.
Spry, Nigel
Gardiner, Robert A.
Levin, Gregory
Wall, Bradley
Joseph, David
Chambers, Suzanne K.
Galvao, Daniel A.
Title A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
Journal name BMC Cancer   Check publisher's open access policy
ISSN 1471-2407
Publication date 2009-06-29
Sub-type Article (original research)
DOI 10.1186/1471-2407-9-210
Volume 9
Issue 210
Start page xx
End page xx
Total pages 8
Editor Fiona Godlee
Melissa Norton
Place of publication London
Publisher BioMed Central
Collection year 2010
Language eng
Subject C1
920102 Cancer and Related Disorders
110602 Exercise Physiology
920504 Men's Health
Formatted abstract Background
Androgen deprivation therapy (ADT) is accompanied by a number of adverse side effects including reduced bone mass and increased risk for fracture, reduced lean mass and muscle strength, mood disturbance and increased fat mass compromising physical functioning, independence, and quality of life. The purpose of this investigation is to examine the effects of long term exercise on reversing musculoskeletal-related side effects, and cardiovascular and diabetes risk factors in men receiving androgen deprivation for their prostate cancer. Specifically, we aim to investigate the effects of a 12-month exercise program designed to load the musculoskeletal system and reduce cardiovascular and diabetes disease progression on the following primary endpoints: 1) bone mineral density; 2) cardiorespiratory function and maximal oxygen capacity; 3) body composition (lean mass and fat mass); 4) blood pressure and cardiovascular function; 5) lipids and glycemic control; and 6) quality of life and psychological distress.

Methods/Design
Multi-site randomized controlled trial of 195 men (65 subjects per arm) undergoing treatment for prostate cancer involving ADT in the cities of Perth and Brisbane in Australia. Participants will be randomized to (1) resistance/impact loading exercise, (2) resistance/cardiovascular exercise groups and (3) usual care/delayed exercise. Participants will then undergo progressive training for 12 months. Measurements for primary and secondary endpoints will take place at baseline, 6 and 12 months (end of the intervention).

Discussion
The principal outcome of this project will be the determination of the strength of effect of exercise on the well established musculoskeletal, cardiovascular and insulin metabolism side effects of androgen deprivation in prostate cancer patients. As this project is much longer term than previous investigations in the area of exercise and cancer, we will gain knowledge as to the continuing effects of exercise in this patient population specifically targeting bone density, cardiovascular function, lean and fat mass, physical function and falls risk as primary study endpoints. In terms of advancement of prostate cancer care, we expect dissemination of the knowledge gained from this project to reduce fracture risk, improve physical and functional ability, quality of life and ultimately survival rate in this population.
Keyword Exercise modalities
Therapy for prostate cancer
Clinical trial
Treatment side-effects
Q-Index Code C1
Q-Index Status Confirmed Code

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 19 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 20 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 87 Abstract Views  -  Detailed Statistics
Created: Wed, 25 Nov 2009, 11:19:48 EST by Deborah Noon on behalf of School of Human Movement Studies